Ferroptosis: Challenges and opportunities for nanomaterials in cancer therapy

Qiaolin Liu, Yuliang Zhao, Huige Zhou, Chunying Chen

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Ferroptosis, a completely new form of regulated cell death, is mainly caused by an imbalance between oxidative damage and reductive protection and has shown great anti-cancer potential. However, existing small-molecule ferroptosis inducers have various limitations, such as poor water solubility, drug resistance and low targeting ability, hindering their clinical applications. Nanotechnology provides new opportunities for ferroptosis-driven tumor therapy. Especially, stimuli-responsive nanomaterials stand out among others and have been widely researched because of their unique spatiotemporal control advantages. Therefore, it's necessary to summarize the application of those stimuli-responsive nanomaterials in ferroptosis. Here, we describe the physiological feature of ferroptosis and illustrate the current challenges to induce ferroptosis for cancer therapy. Then, nanomaterials that induce ferroptosis are classified and elaborated according to the external and internal stimuli. Finally, the future perspectives in the field are proposed. We hope this review facilitates paving the way for the design of intelligent nano-ferroptosis inducers.

Original languageEnglish (US)
Article numberrbad004
Pages (from-to)rbad004
JournalRegenerative Biomaterials
StatePublished - 2023


  • cancer therapy
  • ferroptosis
  • reactive oxygen species
  • stimuli-responsive nanomaterials

ASJC Scopus subject areas

  • Biomaterials


Dive into the research topics of 'Ferroptosis: Challenges and opportunities for nanomaterials in cancer therapy'. Together they form a unique fingerprint.

Cite this